Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB

Int J Mol Med. 2006 Jun;17(6):1005-10.

Abstract

Abnormal activation of the Wnt/beta-catenin pathway and subsequent up-regulation of beta-catenin response transcription (CRT) are associated with the development of colon cancer. Thus, the Wnt/beta-catenin pathway is an attractive target for chemoprevention and treatment of this cancer. We used a cell-based screen to identify a methanol extract of Polysiphonia japonica (EPJ) that suppresses the Wnt/beta-catenin pathway without altering the level of beta-catenin protein and reduces the expression of cyclin D1, which is a known beta-catenin/T cell factor (TCF)-dependent gene. EPJ inhibited the growth of various colon cancer cells. In addition, EPJ induced the nuclear translocation of nuclear factor-kappaB (NF-kappaB) in SW480 colon cancer cells. Our findings suggest that EPJ attenuates Wnt/beta-catenin signaling via activation of NF-kappaB and can potentially be used as a chemopreventive agent against colon cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticarcinogenic Agents / therapeutic use*
  • Biological Products / therapeutic use*
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / prevention & control
  • Cyclin D1 / genetics
  • Down-Regulation
  • Humans
  • NF-kappa B / metabolism*
  • Transcription, Genetic / drug effects
  • Tumor Cells, Cultured
  • Wnt Proteins / antagonists & inhibitors*
  • beta Catenin / antagonists & inhibitors*

Substances

  • Anticarcinogenic Agents
  • Biological Products
  • NF-kappa B
  • Wnt Proteins
  • beta Catenin
  • Cyclin D1